Understanding how our bodies age can help doctors better understand and manage conditions like dementia and other neurological diseases. For many people, the fear of cognitive decline is a significant concern. Researchers are looking for ways to measure biological aging, which is how fast our cells age, rather than just our chronological age in years. This research looked at several different methods for measuring this biological age to see if any of them could help identify risks for dementia.
The researchers conducted a large meta-analysis, which is a study that combines data from many different previous studies to find broader patterns. They looked at data from 46,365 individuals. The researchers tested five different types of DNA-based age clocks. These are tools that look at chemical changes in DNA to estimate how much a person has aged biologically. The five clocks tested were GrimAge, Horvath1, Hannum, PhenoAge, and DunedinPACE.
The results showed that only one of the five tools, called GrimAge, had a significant link to a higher risk of dementia. Specifically, a higher score on the GrimAge scale was associated with an increased risk of developing dementia. The other four clocks tested—Horvath1, Hannum, PhenoAge, and DunedinPACE—did not show a clear or consistent link to dementia risk in this study. This suggests that while some biological clocks are useful for certain health markers, they are not all equally useful for predicting neurological conditions.
It is important to note that this study has several limitations. The evidence for other diseases like Parkinson's or Multiple Sclerosis was inconsistent across the different types of clocks. Additionally, the researchers used a method called Mendelian randomization to see if aging actually caused the disease, but this provided only limited evidence for a direct cause. Because the results were inconsistent across different types of clocks, the findings are not yet strong enough to be used as a definitive medical test.
For patients today, this means that while the GrimAge clock showed a specific link to dementia risk, it is not currently a tool that doctors can use to diagnose or predict the disease in a clinical setting. More research is needed to develop specific tests for different types of neurological conditions. For now, these findings are a step toward understanding how biological aging relates to brain health, but they do not change the current standard of care for patients with dementia or other related conditions.
